Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Cytomegalovirus Infection

Free Subscription Articles published in Blood Retrieve available abstracts of 15 articles: HTML format

Single Articles

March 2021
1. ZAMORA D, Duke ER, Xie H, Edmison BC, et al
   Cytomegalovirus-specific T-cell Reconstitution following Letermovir Prophylaxis after Hematopoietic Cell Transplantation.
   Blood. 2021 Mar 3. pii: 475413. doi: 10.1182/blood.2020009396.
   PubMed     Abstract available
   
   
   
2. GOLDSMITH SR, Abid MB, Auletta JJ, Bashey A, et al
   Post-Transplant Cyclophosphamide (PTCy) is Associated with Increased Cytomegalovirus Infection: A CIBMTR Analysis.
   Blood. 2021 Mar 3. pii: 475412. doi: 10.1182/blood.2020009362.
   PubMed     Abstract available
   
   
   March 2020
3. EINSELE H, Ljungman PT, Boeckh MJ
   How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation.
   Blood. 2020 Mar 20. pii: 452747. doi: 10.1182/blood.2019000956.
   PubMed     Abstract available
   
   
   November 2019
4. KLAIRMONT MM, Gradowski JF
   Hiding in the mantle: mantle cell lymphoma with a mantle zone growth pattern co-occurring with CMV lymphadenitis.
   Blood. 2019;134:1683.
   PubMed    
   
   
   August 2019
5. BENDER IGNACIO RA, Dasgupta S, Stevens-Ayers T, Kula T, et al
   Comprehensive viromewide antibody responses by systematic epitope scanning after hematopoietic cell transplantation.
   Blood. 2019;134:503-514.
   PubMed     Abstract available
   
   
   February 2019
6. AULETTA JJ
   T'ing off on posttransplant CMV.
   Blood. 2019;133:777-779.
   PubMed    
   
   
   December 2018
7. CAMARGO JF, Wieder E, Kimble E, Benjamin C, et al
   Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation.
   Blood. 2018 Dec 20. pii: blood-2018-10-878918. doi: 10.1182/blood-2018-10-878918
   PubMed     Abstract available
   
   
   January 2018
8. COOLEY S, Parham P, Miller JS
   Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.
   Blood. 2018 Jan 22. pii: blood-2017-08-752170. doi: 10.1182/blood-2017-08-752170
   PubMed     Abstract available
   
   
   April 2017
9. HILL JA, Mayer BT, Xie H, Leisenring WM, et al
   The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality.
   Blood. 2017;129:2316-2325.
   PubMed     Abstract available
   
   
   March 2017
10. GUSTAFSSON B
    Is CMV in utero the first event in pediatric ALL?
    Blood. 2017;129:1572-1573.
    PubMed    
    
    
    February 2017
11. ALSULIMAN A, Muftuoglu M, Khoder A, Ahn YO, et al
    A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.
    Blood. 2017;129:740-758.
    PubMed     Abstract available
    
    
    December 2016
12. FRANCIS SS, Wallace AD, Wendt GA, Li L, et al
    In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia.
    Blood. 2016 Dec 15. pii: blood-2016-07-723148.
    PubMed     Abstract available
    
    
    
13. BUNTING MD, Varelias A, Souza-Fonseca-Guimaraes F, Schuster IS, et al
    GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.
    Blood. 2016 Dec 7. pii: blood-2016-08-734020.
    PubMed     Abstract available
    
    
    October 2016
14. LA ROSA C, Longmate J, Martinez J, Zhou Q, et al
    MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T-cells in healthy adults.
    Blood. 2016 Oct 19. pii: blood-2016-07-729756.
    PubMed     Abstract available
    
    
    
15. EL CHAER F, Shah DP, Chemaly RF
    How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.
    Blood. 2016 Oct 19. pii: blood-2016-06-688432.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: